Fabian Arechavaleta-Velasco
5PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 03, 2025
Maternal Bone Mineral Density Changes during Pregnancy: A Longitudinal Prospective Study Using Radiofrequency Echographic Multi-Spectrometry.Fabian Arechavaleta-Velasco, Laura Diaz-Cueto, Sergio Rosales-Ortiz
|Jul 04, 2023
Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer.Fabian Arechavaleta-Velasco, Pablo Dominguez-Lopez, Ernesto Acosta-Jimenez
|Jun 01, 2020
Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype.Carlos Eduardo Perez-Juarez, Fabian Arechavaleta-Velasco, Carmen Mendez
|Nov 13, 2019
Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors.Carlos Eduardo Perez-Juarez, Fabian Arechavaleta-Velasco, Moises Zeferino-Toquero
|Mar 12, 2017
The follicle-stimulating hormone receptor Asn680Ser polymorphism is associated with preterm birth in Hispanic women.Pablo Dominguez-Lopez, Laura Diaz-Cueto, Miguel Arechavaleta-Velasco
Pageof 1
